Tissue Banking Market Forecasts to 2030 - Global Analysis By Product Type, Tissue Bank Type, Storage Technology, Application, End User and By Geography

According to Stratistics MRC, the Global Tissue Banking Market is accounted for $3.6 billion in 2024 and is expected to reach $5.7 billion by 2030 growing at a CAGR of 7.8% during the forecast period. Tissue banking involves the collection, processing, storage, and distribution of human tissue for medical research, education, and transplantation. Tissue banks obtain tissue from deceased donors or living donors during surgical procedures. The retrieved tissue undergoes rigorous testing and processing to ensure its safety and suitability for its intended use. It is then stored under controlled conditions, often cryogenically, until needed for transplantation or research purposes. Tissue banking plays a crucial role in advancing medical science and improving patient care by providing essential resources for research, education, and transplantation.

According to recent data released by the WHO, chronic diseases are one of the world's biggest problems, and they are responsible for roughly 60% of all fatalities globally.

Market Dynamics:

Driver:

Rising prevalence of chronic diseases

The rising prevalence of chronic diseases, such as diabetes, cardiovascular conditions, and cancer, is driving the demand for tissue banking services. As these diseases often require advanced research, personalized treatment, and organ transplants, tissue banks play a crucial role in providing the necessary biological samples. This growing need for specialized tissues for research, diagnostics, and therapeutic purposes is fueling the expansion of the market, supporting advancements in healthcare and precision medicine.

Restraint:

Ethical concerns and regulatory hurdles

Ethical concerns and regulatory hurdles pose significant challenges in the market. Issues surrounding informed consent, donor privacy, and the potential misuse of biological samples create ethical dilemmas. Additionally, stringent regulations on tissue collection, storage, and distribution can slow down research and increase operational costs for tissue banks. These barriers may limit the availability of samples for scientific advancements, hindering progress in medical research, regenerative medicine, and personalized therapies.

Opportunity:

Increasing geriatric population

The increasing geriatric population is significantly impacting the market. As older adults are more susceptible to chronic diseases and require organ transplants or specialized treatments, the demand for preserved biological samples grows. Tissue banks are crucial in providing tissues for research, regenerative medicine, and transplantation, helping to address age-related health issues. This demographic shift is contributing to the expansion of the tissue banking market, driving innovation and improving healthcare outcomes for the elderly.

Threat:

Limited availability of donor tissues

The limited availability of donor tissues is a major challenge in the market, restricting the supply of critical biological samples for research and medical applications. This scarcity can lead to delays in scientific studies, hinder advancements in personalized medicine, and limit treatment options for patients requiring transplants or regenerative therapies. The shortage of donor tissues increases competition among researchers and healthcare providers, potentially driving up costs and reducing access to essential treatments.

Covid-19 Impact:

The COVID-19 pandemic disrupted the tissue banking market by causing delays in sample collection, processing, and distribution due to lockdowns, reduced workforce availability, and restricted access to medical facilities. Research activities were also slowed, as focus shifted to pandemic-related studies. Furthermore, concerns about virus transmission through biological samples raised new ethical and safety considerations. Despite these challenges, the pandemic highlighted the importance of tissue banking in advancing healthcare and research.

The consumables segment is projected to be the largest during the forecast period

The consumables segment is projected to account for the largest market share during the projection period. These include cryopreservation solutions, storage containers, vials, pipettes, culture media, and sterile packaging materials. High-quality consumables are critical for maintaining the integrity of biological samples and ensuring their long-term viability. The growing demand for tissue samples in research and clinical applications is driving increased consumption of these materials, fueling market growth.

The transplantation segment is expected to have the highest CAGR during the forecast period

The transplantation segment is expected to have the highest CAGR during the extrapolated period as stored tissues and organs are crucial for successful transplant procedures. Tissue banks provide preserved samples, such as kidneys, corneas, and bone marrow, for patients in need of life-saving transplants. The growing demand for organ transplants, coupled with advances in preservation and storage techniques, is driving the expansion of tissue banking services, improving transplant outcomes, and addressing organ shortages globally.

Region with largest share:

North America region is projected to account for the largest market share during the forecast period driven by advancements in medical research, transplantation, and personalized medicine. The region benefits from a strong healthcare infrastructure, robust regulatory frameworks, and increased demand for organ transplants and regenerative therapies. Additionally, a rising prevalence of chronic diseases and an aging population are contributing to the demand for preserved tissues.

Region with highest CAGR:

Asia Pacific is expected to register the highest growth rate over the forecast period. Innovations in tissue preservation and processing technologies are enhancing the capabilities of tissue banks. This includes improved cryopreservation techniques and better storage solutions. Stringent regulations are being implemented to ensure ethical practices in tissue banking, which can both facilitate growth by ensuring safety and potentially restrain it due to compliance costs.

Key players in the market

Some of the key players in Tissue Banking market include AMS Biotechnology Limited, BioLife Solutions, Inc., Beckman Coulter, Bio-Rad Laboratories Inc., Thermo Fisher Scientific Inc., Lonza Group AG, Corning Incorporated, Helmer Scientific, Irvine Scientific, Medtronic plc, Paragon Bioservices, Inc., The Cooper Companies, Inc., TissueGenesis, Inc., ViGene Biosciences, Inc. and Fujifilm Cellular Dynamics.

Key Developments:

In July 2023, Bio-Rad Laboratories, Inc. and QIAGEN N.Vannounced that the companies have agreed to settle their patent dispute pending in the U.S. District Court of Delaware pursuant to a global settlement and patent cross-licensing agreement relating to digital PCR technology.

In May 2023, Pfizer and Thermo Fisher Scientific Inc. announced they have entered into a collaboration agreement to help increase local access to next-generation sequencing (NGS)-based testing for lung and breast cancer patients in more than 30 countries where advanced genomic testing has previously been limited or unavailable.

Types Covered:

• Tissue Preservation Media
• Consumables
• Storage Systems & Equipment
• Laboratory Instruments & Equipment
• Preservation & Processing Kits
• Other Types

Tissue Bank Types Covered:

• Human Tissue Banks
• Animal Tissue Banks

Storage Technologies Covered:

• Cryopreservation
• Freezing
• Lyophilization
• Cold Storage
• Perfusion Systems

Applications Covered:

• Research & Development (R&D)
• Regenerative Medicine
• Diagnostic Applications
• Transplantation
• Other Applications

End Users Covered:

• Hospitals & Surgical Centers
• Research Institutes
• Biotechnology & Pharmaceutical Companies
• Blood and Organ Banks
• Other End Users

Regions Covered:

• North America
  • US
  • Canada
  • Mexico
• Europe
  • Germany
  • UK
  • Italy
  • France
  • Spain
  • Rest of Europe
• Asia Pacific
  • Japan
  • China
  • India
  • Australia
  • New Zealand
  • South Korea
  • Rest of Asia Pacific
• South America
  • Argentina
  • Brazil
  • Chile
  • Rest of South America
• Middle East & Africa
  • Saudi Arabia
  • UAE
  • Qatar
  • South Africa
  • Rest of Middle East & Africa

What our report offers:

• Market share assessments for the regional and country-level segments
• Strategic recommendations for the new entrants
• Covers Market data for the years 2022, 2023, 2024, 2026, and 2030
• Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
• Strategic recommendations in key business segments based on the market estimations
• Competitive landscaping mapping the key common trends
• Company profiling with detailed strategies, financials, and recent developments
• Supply chain trends mapping the latest technological advancements

Free Customization Offerings:

All the customers of this report will be entitled to receive one of the following free customization options:

• Company Profiling
  • Comprehensive profiling of additional market players (up to 3)
  • SWOT Analysis of key players (up to 3)
• Regional Segmentation
  • Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
• Competitive Benchmarking
  • Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances